The value of proteinuria for the administration of rituximab in patients with PLA2R-associated membranous nephropathy: a single-centre retrospective analysis
Objective Studies have shown that the efficacy of rituximab (RTX) in patients with M-type phospholipase A2 receptor (PLA2R)-associated primary membranous nephropathy (PMN) is related to proteinuria. However, definitive evidence to guide the initiation of RTX therapy based on proteinuria excretion le...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis Group
2026-12-01
|
| Serie: | Annals of Medicine |
| Soggetti: | |
| Accesso online: | https://www.tandfonline.com/doi/10.1080/07853890.2026.2683170 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|